Alex Nemiroff
General Counsel bij PRAXIS PRECISION MEDICINES, INC.
Vermogen: 192 640 $ op 31-03-2024
Profiel
Alex Nemiroff is the founder and Chief Executive Officer of RogCon, Inc., which was founded in 2015.
He is also the founder and Chief Executive Officer of RogCon U.R., Inc., which is also founded in 2015.
Currently, Mr. Nemiroff holds the position of Secretary & General Counsel at Praxis Precision Medicines, Inc. since 2020.
In terms of education, Mr. Nemiroff has an undergraduate degree from Stephen M.
Ross School of Business and a graduate degree from Northwestern University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-02-2024 | 3 157 ( 0.02% ) | 192 640 $ | 31-03-2024 |
Actieve functies van Alex Nemiroff
| Bedrijven | Functie | Begin |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | General Counsel | 01-01-2020 |
RogCon, Inc.
 RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Chief Executive Officer | 01-11-2015 |
| RogCon U.R., Inc. | Chief Executive Officer | 01-11-2015 |
Opleiding van Alex Nemiroff
| Stephen M. Ross School of Business | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Health Technology |
| RogCon U.R., Inc. |
